Table 1.
Clinical characteristics of patients with CC in TCGA database.
| Clinical characteristics | Subgroup | Frequency | Percentage (%) |
|---|---|---|---|
| Total | 304 | ||
| Age | Range:20-88 (average: 48.2, median: 46) | ||
| BMI | Range: 13.4-70.5 (average: 27.9, median: 26.6) | ||
| Histology | Squamous cell carcinoma (SCC) | 252 | 89.0 |
| Adenomas and adenocarcinoma (ACC) | 31 | 11.0 | |
| Keratinization | No | 119 | 68.4 |
| Yes | 55 | 31.6 | |
| Hormone use | No | 89 | 56.7 |
| Yes | 68 | 43.3 | |
| Hysterectomy | Other | 8 | 4.8 |
| Hysterectomy | 159 | 95.2 | |
| Tumor size | T1+T2 | 211 | 87.6 |
| T3+T4 | 30 | 12.4 | |
| Lymph node | N0 | 133 | 68.9 |
| N1 | 60 | 31.1 | |
| ∗FIGO stage | ≤IIA2 (early stage) | 188 | 63.3 |
| ≥IIB (late stage) | 109 | 36.7 | |
| Differentiation grade | ≤G2 | 153 | 56.3 |
| ≥G3 | 119 | 43.7 | |
| Lymphovascular invasion | Absent | 71 | 47.3 |
| Present | 79 | 52.7 | |
| Distant metastasis | No | 273 | 89.8 |
| Yes | 31 | 10.2 | |
| Vital status | Alive | 233 | 76.6 |
| Dead | 71 | 23.4 |
∗FIGO stage: there were five samples only described as FIGO II without specific stages. We classified these samples as ≤IIA2 in this study. BMI: body mass index; FIGO: the International Federation of Gynecology and Obstetrics.